Sort
21,453 grants matching “tuberculosis”
Novel Diagnostic Development for TB Meningitis and Histoplasmosis
$200,880Nathan Bahr · University Of Kansas Medical Center · K23 · FY2019 · NS
Mechanisms of a therapeutic DNA vaccine targeting Mycobacterium tuberculosis persisters
$200,880Styliani Karanika · Johns Hopkins University · K08 · FY2025 · AI
Mechanisms of a therapeutic DNA vaccine targeting Mycobacterium tuberculosis persisters
$200,880Styliani Karanika · Johns Hopkins University · K08 · FY2024 · AI
Subcellular Mechanisms for Fungal Phagosome Maturation in Macrophages
$200,880Michael K Mansour · Massachusetts General Hospital · K08 · FY2017 · AI
Molecular determinants of lung cancer in HIV infected and uninfected individuals in Uganda and Tanzania
$200,857Stanton L Gerson · Case Western Reserve University · U54 · FY2023 · CA
CONJUGATION AND RECOMBINATION IN MYCOBACTERIA
$200,723Wadsworth Center · R01 · FY2003 · AI
Emory/Georgia TB Research Advancement Center (TRAC)
$200,709Cheryl Liane Day · Emory University · P30 · FY2023 · AI
Novel Diagnostic Development for TB Meningitis and Histoplasmosis
$200,705Nathan Bahr · University Of Kansas Medical Center · K23 · FY2021 · NS
Novel Diagnostic Development for TB Meningitis and Histoplasmosis
$200,705Nathan Bahr · University Of Kansas Medical Center · K23 · FY2020 · NS
Novel Diagnostic Development for TB Meningitis and Histoplasmosis
$200,705Nathan Bahr · University Of Kansas Medical Center · K23 · FY2022 · NS
STATEWIDE TUBERCULOSIS CONTROL AND LABORATORY PROGRAM.SD
$200,625Colleen M. Winter · South Dakota State Dept Of Health · U52 · FY2015 · PS
Protein Expression and Antibody Development
$200,580Timothy A Cross · Florida State University · P01 · FY2009 · AI
STS Social Studies of Science: Compound Solutions
$200,433Susan L Craddock · University Of Minnesota-Twin Cities · · FY2010 · SBE
M TUBERCULOSIS SIGH AND ITS REGULON IN THE IMMUNOPATHOLOGY OF TUBERCULOSIS
$200,376Deepak Kaushal · Louisiana State Univ A&M Col Baton Rouge · P20 · FY2008 · RR
Antibody profiles characteristic of tuberculosis state
$200,374Public Health Research Institute · R21 · FY2005 · AI
Inhibitors of Mycobacterium tuberculosis FAS-II dehydratases
$200,240Mary Jackson · Colorado State University · R21 · FY2021 · AI
MODELING CELLULAR IMMUNITY DURING HIV AND TB INFECTIONS
$200,115University Of Michigan At Ann Arbor · R01 · FY2002 · HL
The impact of mucociliary clearance on Mycobacterium tuberculosis pathogenesis
$200,075Javeed Ali Shah · University Of Washington · R21 · FY2024 · AI
Building Tuberculosis Clinical Research Capacity in China
$200,039David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2013 · CA
DAIDS RePORT India Consortium
$200,000National Institute Of Allergy And Infectious Diseases · Y01 · FY2015 · AI
West Africa Center of Excellence for Data Science Research Education
$200,000Seydou Doumbia · Univ Of Sciences, Tech & Tech Of Bamako · UE5 · FY2024 · TW
Biosynthesis and medicinal chemistry of the capuramycin antimycobacterial antibiotics
$200,000Steven Gary Van Lanen · University Of Kentucky · R01 · FY2019 · AI
Biosynthesis and medicinal chemistry of the capuramycin antimycobacterial antibiotics
$200,000Steven Gary Van Lanen · University Of Kentucky · R01 · FY2021 · AI
Columbia University-Southern African AIDS International Training/Research Program
$200,000Quarraisha Abdool Karim · Columbia University Health Sciences · D43 · FY2010 · TW
Disease-related defects in dendritic cell processing of bacterial antigens
$200,000Michael S Marks · University Of Pennsylvania · R21 · FY2012 · AI